Research Paper Volume 15, Issue 18 pp 9676—9694
Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma
Figure 7. The expression and clinical significance of WDFY4 in LUAD. (A, B) Tissue microarray (TMA) analysis by IHC staining showed a low expression of WDFY4 in LUAD tissues. (C) High and low expression rates of WDFY4 in LUAD tissue. (D) Kaplan-Meier analysis showed that LUAD patients with downregulation of WDFY4 were positively correlated with worse prognosis and shorter overall survival. (E) Correlations of WDFY4 expression levels in LUAD tissues and clinicopathological features.